Marc Bonaca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Early Win for Preemptive Stents on Vulnerable Coronary Plaque

Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial

New zealandSoult ukpyolsiSouth koreaBrown universityRhode islandUnited statesJosip andelo borovacNicole louMarc bonacaAmerican college of cardiologyUniversity of ulsan college medicineLifespan cardiovascular institute in providenceUniversity of colorado school medicineAsan medical centerSeung jung parkUlsan college

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

While the field awaits targeted therapies, estimates of absolute 10-year risks can be used to counsel patients, researchers say.

United statesPetere thomasMarcp bonacaMarc bonacaEli lillyJoshuaa beckmanPiar kamstrupAlexandere sullivanMd vanderbilt university medical centerCopenhagen university hospitalUniversity of colorado school medicineJournal of the american college cardiologyMd ut southwestern medical centerAmerican college of cardiology vascular disease councilNovartis ionis pharmaceuticalsMd university of copenhagen

TRANSFORM Trial Unveiled: AI-Powered Approach for Personalized Heart Disease Care

Cleerly and partners embark on the groundbreaking TRANSFORM trial, harnessing AI s power to personalize heart disease care and..

United statesDavid maronDeepakl bhattMarc bonacaHeartbeat healthAmerican heart associationClinical researchIcahn school of medicine at mount sinaiCardiovascular researchVascular researchStanford university school of medicineLexicon pharmaceuticalsStanford prevention research centerUniversity of colorado school medicinePreventing heartMount sinai fuster heart hospital

Experts Perspectives: Top News in Cardiology for 2023

A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.

United statesUnited kingdomPaul ridkerJamese ipMuthiah vaduganathanMandeep mehraViett leAhmad masriSadiya khanMarc bonacaDeepak bhattSadiyas khanJames ipSteve nissenSteve greeneRahul aggarwal

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarcp bonacaMarc bonacaJanssen scientific affairsJanssen pharmaceuticals incExchange commissionDrug administrationJanssenus janssen scientific affairsDivision of cardiovascular medicineNone of janssen scientific affairsDepartment of medicineCompanies of johnsonJanssen pharmaceutical companies of johnsonAmerican heart associationUniversity of colorado anschutz medical campusJanssen pharmaceutical companies